SAN DIEGO–(BUSINESS WIRE)–Lassen Therapeutics, a biotech company developing breakthrough antibody therapeutics as potential treatments for fibrosis, rare diseases and oncology, today announced plans to present a poster on IL-11 receptor-blocking as a novel therapeutic approach for lung fibrosis at the upcoming Keystone Symposia Conference on Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies being held in Keystone, Colorado, June 12-16, 2022. The presentation will describe de Click here to view original post
News
AB Nexus Announces New Grant Awards With a Focus on Research Collaborations Related to AI and Climate Change
Today, the AB Nexus program announced its 2024 seed grant awards to interdisciplinary research teams from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder. Collectively, the seven winning teams will […]
News
Czech Olympian Petr Svoboda Credits Igniton for Help in Setting Masters World Record, Marking Extraordinary Comeback After Severe Injury
BOULDER, Colo., March 19, 2026 /PRNewswire/ — Former Olympian and European Indoor Champion Petr Svoboda has set a new Masters (M40) world-level performance in the 60-meter hurdles (7.78 sec.), completing a remarkable return to elite […]
News
Revelation Pharma Announces Revelation Wholesale, an Extension of Its National Compounding Network
This new addition from the leading compounding pharmacy business will enable healthcare providers to meet and exceed the unique needs of their patients CASTLE ROCK, Colo., Sept. 17, 2024 /PRNewswire/ — Revelation Pharma, a national […]
